In this in vivo study, the time course of plasma concentration and the urinary excretion of ethyl -Dglucoside (-EG) and ethyl -D-glucoside (-EG) were investigated in rats after a single oral dose of 4 mmol/kg body weight. Maximal plasma concentrations of both -EG and -EG (EGs) reached approximately 3 mM at 1 h after oral administration and then decreased rapidly. Approximately 80% of EGs administered were excreted into the urine during the first 6 h. Within 24 h, cumulative urinary -EG and -EG excretions were estimated to be 87:2 AE 7:9% and 85:4 AE 5:0%, respectively. Traces of both EGs were detected in plasma and urine 24 h after oral ingestion. The results of this study indicate that almost all of both EGs was rapidly absorbed into the blood stream and easily excreted into the urine after oral administration, and that a small amount of them remained in the rat body 24 h after administration.
Sake, a traditional Japanese alcoholic beverage, regularly contains 0.1-0.4% of ethyl -D-glucoside (-EG). [1] [2] [3] [4] Ethyl -D-glucoside (-EG) has been reported to be contained in the peal of yuzu (Citrus junos S IEB ). 5) Sake and yuzu peal have been used in cooking as a flavor enhancer in Japan from ancient times, which means that Japanese have ingested -EG and -EG from sake and yuzu for long periods. Recently, -EG and -EG were reported to have physiological effects. Hirotsune et al. reported that ingestion of sake concentrate improved skin barrier disruption induced by UVB irradiation, and that the same effect was evident in rats supplied -EG only. 6) On the other hand, Matsubara et al. reported that -EG showed a blood pressure decreasing effect in SHRrats after intravenous injection of -EG. 5) To explain the mechanism of these physiological effects, it is important to investigate the plasma kinetics of EGs. In a previous paper, we reported that -EG was transported though the rat small intestinal wall 7) and was detected in the plasma and urine of the rats fed -EG. 8, 9) Some researchers have reported that -EG and -EG were transported through the small intestinal wall, 10, 11) indicating that -EG ingested orally might be absorbed into blood stream through the small intestinal wall as well as -EG. Our previous study suggested that approximately 60-80% of the -EG ingested was recovered from the urine of rats within 24 h, 8, 9) but changes in the plasma concentration and urine excretion of EGs after oral administration have not been investigated. In the current study, we examined the plasma kinetics and urine profile of EGs after single oral administrations to rats.
Materials and Methods
Materials. -EG was purified from commercial sake, which was kindly supplied by Ozeki Co. (Nishinomiya, Japan), and -EG was synthesized at the Basic Research Laboratory of Kanebo Cosmetics (Odawara, Japan). Other reagents were purchased from Nacalai Tesque (Kyoto, Japan). Male Wistar ST clean rats (8 weeks old, 240-260 g) were purchased from Japan SLC (Hamamatsu, Japan). The care and use of rats in the present study followed the guidelines of governmental legislation in Japan on the proper use of laboratory animals (1980), and our experiments were approved by the Ethics Committee of the Faculty of Applied Biological Sciences of Gifu University. [10] [11] [12] Indwelling cannula was used to withdraw blood after oral administration of -EG or -EG. The cannulated rats were housed individually for 4 d, and the patency of the cannula was checked once per d by flushing with physiological saline containing heparin.
Blood sample collection after oral administration of EGs. After starvation for 24 h, a basal blood sample (200 ml) was taken, and then the rats received oral administration of -EG or -EG dissolved in physiological saline (4 mmol/kg of body weight, 1 ml). The rats had free access to the AIN-76 based diet for 6 h after oral administration. Blood samples (200 ml) were taken at 0.25, 0.5, 1, 2, 6, 12, and 24 h after oral administration with a heparinized syringe. All blood samples were centrifuged for 1 min at 12;000 Â g at 4 C. Plasma was collected and stored at À20 C until analysis. High performance anion exchange chromatography with amperometric detection for plasma EG analysis. The intact forms of EGs were detected by high performance anion exchange chromatography by the amperometric detection (HPAEC-PAD) method. Solvent delivery was via an L-6320 Intelligent metal free pump (Hitachi High Technologies, Tokyo) equipped with a metal free sample injector (model 9125, Rheodyne) and a 20-ml sample loop. Separation was achieved using a CarboPac PA1 column (guard column, 4 Â 50 mm, and analytical column, 4 Â 250 mm), purchased from Dionex Japan (Tokyo). The 0.3-M NaOH mobile phase was filtered with 0.45 mm PTFE membrane filters (Millipore, Billerica, MA). The mobile phase was degassed by sonication under reduced pressure. The flow rate was 1.0 ml/min throughout the experiment. The amperometric detection cell (Radial Flow Cell, BAS, West Lafayette, IN) was comprised of an Au working electrode (6 Â 1:6 mm, BAS), an Ag/AgCl reference electrode (RE-3V, BAS), and a Pt wire counter electrode (BAS). Waveform was applied using a model Power Lab/200 (ADInstruments, Bella Vista, Australia) and a model ML160 potentiostat (ADInstruments). Potentiostat control and data acquisition were done using Echem Scientific Software (ver.1.5.2, ADInstruments) and chromatogram analysis was done using PowerChrom (ver.2.2.4, ADInstruments) installed in a personal computer. The following pulse potentials and durations were used: the detection potential was 200 mV (0.4 s), the oxidation potential was 800 mV (0.2 s), and the reduction time was À400 mV (0.4 s).
A plasma sample (100 ml) was mixed with 2 N of perchloric acid (150 ml) and centrifuged at 12;000 Â g for 10 min to remove protein. The supernatant was collected and was added 200 mg of AG501-X8 resin (BioRad Laboratories, Tokyo). After shaking, resin was removed from the sample, and then 200 mg of fresh resin was added again. The resulting supernatant (150 ml) was mixed with 50 ml of 1.2 M NaOH. The samples were filtered with a PTFE membrane cartridge (0.45 mm, Millipore), and then 20 ml of filtrate was injected into the column.
Urine sample collection after oral administration of EGs. The rats were housed individually in a metabolic cage (Natsume Seisakusho, Tokyo), and starved for 24 h. During the starvation period, urine was collected (blank, 0 h). On the following day, -EG or -EG dissolved in physiological saline (4 mmol/kg body weight, 1 ml) was administered orally to the rats by stomach tube. The rats had free access to the AIN-76 based diet for 6 h after oral administration. Urine samples were collected in a sample tube at 3, 6, 12, and 24 h after oral administration of -EG or -EG, and stored at À20 C until analysis. High performance liquid chromatography apparatus for urinary EGs analysis. The intact forms of urinary EGs were determined by a modified high performance liquid chromatography (HPLC) method, as indicated in previous papers. 8, 9) The HPLC system, LC-VP series (Shimadzu, Kyoto, Japan) equipped with a refractive index detector (RID-10A, Shimadzu) and a Shodex Asahipack NH 2 P-50 column (Showa Denko, Kawasaki, Japan) was used. The column was eluted under isocratic condition with 90% CH 3 CN and 10% H 2 O. The column temperature was maintained at 40 C. The flow rate was set at 1.0 ml/min throughout the experiment. Urine samples were diluted with deionized water or concentrated under reduced pressure appropriately. Each urine sample was passed through a DISMIC-25CS membrane filter (Advantec Toyo, Tokyo), and then 10 ml of filtrate was injected into the column.
Statistical analysis. Data are shown as average AE SE for six samples. The significant difference between data from the -EG and -EG groups on respective sampling times was estimated at P < 0:05 according to Student's t-test.
Results Figure 1 shows a typical HPAEC-PAD chromatogram of a plasma sample collected from the rats fed -EG (A, B, and C) or -EG (D, E, and F). The retention times (Rt) for -EG and -EG were 108 and 107 s respectively. Almost all the glucose was removed from the plasma sample by resin treatment (Rt; 184 s). Figure 2 shows a typical HPLC chromatogram of a urine sample collected from the rats fed -EG (A, B, and C) or -EG (D, E, and F). The retention times for -EG and -EG were 463 and 526 s respectively. Glucose was not detected in the urine samples. As shown in Fig. 1A, D and Fig. 2A , D, plasma and urine samples collected before the administration of -EG or -EG (blank, 0 h) contained no -EG or -EG. Figure 3 shows the plasma kinetics and urinary excretion profiles for -EG in the rats after a single oral administration of -EG, and Fig. 4 shows those for -EG. The maximal concentrations of -EG (2:94 AE 0:15 mM) and -EG (3:11 AE 0:41 mM) in the plasma occurred 1 h after administration. Subsequently, the plasma concentrations of EGs declined rapidly. During the first 6 h, urinary excretion of -EG and -EG were 0:826 AE 0:164 mol and 0:783 AE 0:062 mol respectively. Within 24 h, cumulative total urinary excretion of -EG and -EG was estimated to be 0:876 AE 0:079 mol (87:2 AE 7:9%) and 0:855 AE 0:053 mol (85:4 AE 5:0%) respectively. Small amounts of -EG (0:0027 AE 0:0008 mol) and -EG (0:0022 AE 0:0014 mol) were detected in the urine even in the 24-48 h period (data not shown).
The half-lives of -EG and -EG in the plasma after oral administration were 4:26 AE 0:88 h and 5:17 AE 1:30 h respectively. Furthermore, the half-lives estimated by urine excretion of -EG and -EG after oral administration were 3:60 AE 0:26 h and 3:93 AE 0:57 h respectively. The AUCs of -EG and -EG in the plasma were 9:5 AE 0:8 mmolÁh/l and 11:1 AE 1:1 mmolÁh/l respectively. With these parameters, there were no statistical significant differences between -EG and -EG.
Discussion
Recently, some researchers have reported physiological effects of -EG and -EG. 5, 6) To clarify the mechanisms of these effects, changes in the concentrations of -EG and -EG in body had to be investigated. In this study, we examined the plasma kinetics and urine profile of EGs after a single oral administration using rats.
Our previous data suggested that -EG is transported through the rat small intestinal wall. 7) Furthermore, -EG was detected in the plasma of rats fed -EG solution as a daily drink. 8) As shown in Fig. 3 , the plasma -EG concentration reached a maximal value at 1 h after oral administration, and then rapidly decreased. As for urinary excretion of -EG, approximately 80% of -EG was recovered within 6 h after oral administration. In this experiment, rapid absorption into the blood stream and immediate transfer into the urine of -EG appeared.
In addition, we examined the plasma kinetics and urine profiles of -EG. Landau et al. found that -EG was effectively concentrated in the everted hamster intestinal sac, 13) and Ramaswamy et al. found that hamster intestinal Na þ -dependent glucose carrier showed affinity to -EG. 14) These might be the reasons -EG showed similar profiles to -EG in plasma concentration and urine excretion. Mizuma et al. reported that SGLT1 preferred the -anomer of the glucose conjugate, 15) but no significant differences between -EG and -EG appeared in this in vivo experiment.
Approximately 20% of -EG was not excreted into the urine at 24 h after oral administration. Our previous study found that -EG hydrolyzing enzymes were distributed in the rat small intestine and kidney. 8) Some -EG was hydrolyzed in the small intestinal mucosa before absorption, and subsequently -EG absorbed into blood stream was presumably metabolized in the kidneys, but in an in vitro examination, hydrolyzing activity for -EG was much lower than that for disaccharides. 7, 8) Hence ingested -EG was not hydrolyzed completely, and consequently it was excreted into the urine. On the other hand, the -EG administered was recovered from the urine as well as -EG. Although we did not examine -EG hydrolyzing enzymes, severalglucosides are known have been to hydrolyze in animal bodies. [16] [17] [18] Hence some -EG might have been metabolized after oral ingestion.
In plasma collected at 24 h, small amounts of -EG and -EG were detected. Furthermore, small quantities of -EG and -EG were detected in urine collected in the 24-48 h period (data not shown). According to Teague et al., -EG was detected up to 28 h after ingestion in the urine of a man who took sake. 19) These data indicate that a portion of -EG and -EG escaped metabolism and excretion and remained in body even 24 h after oral administration. Although this study did not examine whether both EGs disappeared from the body, they were surmised to be metabolized and excreted into the urine in the end.
In conclusion, -EG and -EG were rapidly absorbed into the blood stream and were easily excreted into the urine after oral administration, and a small amount of them remained in the body 24 h after administration.
